Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19033,913,2.27 [1.82-2.81],1.344395392158203e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,18281,292,3.70 [2.59-5.29],8.019978665155976e-13
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,21577,181,1.64 [1.03-2.61],0.0388107019467136
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13371,1090,2.57 [2.08-3.17],1.1078119497600346e-18
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21530,134,1.39 [0.80-2.40],0.2450390348825536
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19084,96,2.82 [1.50-5.27],0.0012148106775158
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22993,133,1.31 [0.76-2.28],0.3337644906616823
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22980,89,0.97 [0.49-1.95],0.9391606904840336
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18584,72,3.16 [1.54-6.49],0.0017396285301362
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,21833,130,2.31 [1.34-3.98],0.002502447242368
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,21790,87,2.48 [1.28-4.78],0.0067928640624747
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23101,70,1.91 [0.90-4.05],0.0918406291001651
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23131,65,0.97 [0.43-2.19],0.949624179494266
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23128,62,1.23 [0.54-2.79],0.6174541151561113
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,22630,61,1.18 [0.51-2.71],0.7013286540077396
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",21510,439,2.39 [1.78-3.22],9.5890198087557e-09
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21210,139,2.99 [1.79-4.99],2.709507446747718e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21389,318,2.21 [1.56-3.14],9.252259920231048e-06
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",16628,103,1.14 [0.60-2.18],0.6918240382977772
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16588,63,0.81 [0.34-1.92],0.6284263800542753
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16924,399,1.13 [0.81-1.59],0.4791459308789965
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16935,410,1.12 [0.80-1.56],0.5238341029601516
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",9509,384,1.36 [0.95-1.93],0.0890536800271391
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7608,208,1.33 [0.85-2.08],0.2130331040212034
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16583,58,5.14 [2.50-10.57],8.661079764381422e-06
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19737,774,3.18 [2.53-3.99],2.095419618078556e-23
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",21596,474,1.69 [1.26-2.26],0.0004482228147868
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22593,159,1.43 [0.86-2.37],0.1653141388769441
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23193,149,1.63 [0.98-2.72],0.0620648230399219
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,22865,88,3.03 [1.62-5.66],0.0005056897267485
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23197,95,1.41 [0.73-2.74],0.3100566336964695
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Stomach,23251,69,0.97 [0.43-2.17],0.9413346444657116
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,23006,293,1.15 [0.79-1.68],0.4693827732751493
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23232,100,1.52 [0.81-2.85],0.1958477401472628
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23236,84,0.67 [0.32-1.38],0.277525231795418
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23148,58,0.75 [0.31-1.82],0.5247972836757522
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",23151,57,0.70 [0.28-1.71],0.4321647207828478
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,23089,148,1.35 [0.79-2.30],0.276241285322414
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23229,64,0.96 [0.42-2.21],0.9305819106005708
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,23111,178,0.97 [0.59-1.59],0.9002142717445667
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of breast,12137,45,0.76 [0.27-2.08],0.5872176863254532
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Leiomyoma of uterus,11994,306,1.07 [0.72-1.58],0.7406317382471896
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,21659,197,3.34 [2.19-5.08],1.8885780508470835e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21123,354,2.94 [2.13-4.07],7.857156019461386e-11
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21123,354,2.94 [2.13-4.07],7.857156019461386e-11
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18552,572,2.10 [1.60-2.75],9.106027830166333e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22624,59,2.99 [1.36-6.61],0.0066438420293959
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22907,59,0.68 [0.28-1.63],0.3890745236626612
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,16779,1663,1.80 [1.52-2.13],1.2321288876500676e-11
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,21502,642,1.63 [1.26-2.10],0.0001954370136948
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20427,154,3.26 [1.99-5.33],2.5298029313742493e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21628,170,2.41 [1.52-3.81],0.0001659060739765
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20414,141,3.35 [2.01-5.59],3.6760471488037313e-06
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21057,784,3.85 [3.06-4.84],1.1914382184652127e-30
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21030,757,3.72 [2.95-4.70],2.722549402054477e-28
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,21350,186,1.20 [0.72-1.99],0.4808020864797595
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",21349,185,1.20 [0.72-1.99],0.4821707442475166
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16593,1477,1.70 [1.42-2.03],7.089419045944584e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15308,192,1.37 [0.85-2.20],0.2002386934793555
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,16482,1366,1.72 [1.43-2.07],9.78417585431493e-09
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15175,59,2.59 [1.16-5.78],0.0203658877455398
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15209,93,1.83 [0.95-3.55],0.0729352384369187
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,19018,527,2.03 [1.54-2.68],5.803757865975295e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",18648,157,4.16 [2.60-6.64],2.413503143989319e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22878,112,4.63 [2.71-7.93],2.2872936626250185e-08
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22938,83,6.51 [3.57-11.86],9.572943016086535e-10
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21691,34,1.81 [0.62-5.24],0.2767913787531165
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23172,34,1.60 [0.55-4.61],0.3870419862968727
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",18525,34,1.81 [0.63-5.22],0.2704113834123994
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,21699,42,,
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,21621,47,3.41 [1.49-7.80],0.0036006016122264
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18526,35,0.87 [0.28-2.67],0.8097288817778119
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",18746,255,1.70 [1.14-2.54],0.0095927081682714
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,21782,228,1.62 [1.07-2.46],0.0240379299307534
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,18384,195,1.82 [1.16-2.88],0.009873075127408
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",18598,107,1.44 [0.77-2.68],0.255544109665016
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Other anxiety disorders,21839,61,0.97 [0.42-2.24],0.9369861003115888
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,18879,1501,1.81 [1.52-2.15],1.838417212336864e-11
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16508,102,3.05 [1.67-5.57],0.00028074623131
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23156,77,2.60 [1.31-5.16],0.0064264091850378
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,21913,468,1.71 [1.27-2.30],0.00035838031209
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,21580,135,2.20 [1.29-3.75],0.0038783330716085
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,21502,57,1.60 [0.69-3.74],0.275504139612854
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23018,52,1.42 [0.59-3.44],0.4326968019817117
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22073,117,1.47 [0.82-2.64],0.1985712295412868
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,21603,158,1.35 [0.81-2.25],0.2475722557818646
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,22713,117,0.99 [0.54-1.80],0.9730503268256436
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22040,715,1.30 [1.02-1.66],0.0364765564879208
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21430,105,1.30 [0.70-2.43],0.4083875848897644
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21765,440,1.13 [0.82-1.54],0.4523031874307323
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22863,80,1.82 [0.91-3.63],0.0882158827631667
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,22844,61,2.17 [1.01-4.69],0.0481167973475405
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,22679,121,2.01 [1.14-3.53],0.0152746911876137
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22383,421,0.99 [0.72-1.37],0.9605024369656712
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22219,257,1.16 [0.78-1.74],0.4653641369222514
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22022,60,0.62 [0.26-1.48],0.2820524091186723
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22098,136,0.90 [0.51-1.58],0.7064460081572723
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22066,104,0.75 [0.39-1.43],0.3796904147468565
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17786,257,1.40 [0.94-2.09],0.1013101074278321
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18146,617,1.46 [1.12-1.90],0.0046512257900696
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,21840,307,0.85 [0.58-1.24],0.4040621239357544
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22825,81,2.37 [1.20-4.65],0.0124529254919531
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2617,81,1.02 [0.52-2.03],0.9458647646594972
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20289,81,2.92 [1.48-5.78],0.0020579270951984
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22254,143,1.17 [0.68-2.01],0.5787631280484611
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22189,78,1.11 [0.53-2.31],0.7867985643868286
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22324,78,1.93 [0.96-3.87],0.0632774226846267
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22561,98,1.62 [0.86-3.06],0.1343453212311041
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23157,144,1.55 [0.91-2.64],0.1065652037816987
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22028,112,0.59 [0.31-1.11],0.1004970889814412
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,14300,4599,1.75 [1.54-1.99],5.608005957037342e-18
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22285,94,1.66 [0.87-3.18],0.1259786393338901
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",15159,3219,1.80 [1.56-2.06],1.2340185784994287e-16
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,15201,3261,1.77 [1.54-2.03],4.4129517465896973e-16
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12049,109,1.04 [0.55-1.99],0.8984505255184406
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20346,1836,1.52 [1.30-1.78],2.0873748024610134e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,19600,1090,1.71 [1.40-2.09],1.255570118901283e-07
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21850,342,1.96 [1.40-2.74],7.637756856459976e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22206,698,1.46 [1.14-1.86],0.0023430619265187
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23089,134,1.10 [0.63-1.92],0.739157582005334
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18947,437,1.32 [0.97-1.80],0.0795592488633076
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,19974,1489,1.53 [1.28-1.82],1.804117270285304e-06
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22103,136,1.62 [0.94-2.79],0.0803316406035358
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22322,280,1.44 [0.98-2.10],0.0625014456519488
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22085,118,1.80 [1.01-3.22],0.0455198759886952
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22086,119,1.84 [1.03-3.27],0.0381480614925491
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12054,114,2.14 [1.17-3.90],0.0132722977216691
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,17057,71,1.96 [0.92-4.15],0.0791092898987641
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,17160,174,1.13 [0.69-1.87],0.6210007836908213
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9044,143,0.58 [0.32-1.04],0.0684091287065625
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9592,691,1.71 [1.31-2.24],7.60936950526748e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,17080,94,1.39 [0.72-2.72],0.3283226677846083
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17108,122,1.62 [0.91-2.89],0.1036605745537881
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",21594,292,1.86 [1.28-2.68],0.0010177763932311
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",21967,197,2.38 [1.54-3.68],9.165775538462736e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22003,177,2.44 [1.54-3.85],0.0001351805169855
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22113,157,2.37 [1.45-3.85],0.0005228228674708
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21602,109,1.91 [1.06-3.45],0.0308583433683398
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21667,174,2.13 [1.35-3.37],0.0012620549207417
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21525,167,1.36 [0.83-2.24],0.2200861083189782
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21504,146,1.65 [0.98-2.78],0.0598115344854135
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22972,140,1.62 [0.96-2.75],0.0721778904560138
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,21868,510,1.03 [0.77-1.39],0.83673920070988
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,21542,118,1.45 [0.80-2.63],0.2254322875351661
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17125,2172,2.02 [1.74-2.35],7.008976050967414e-20
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23092,78,1.55 [0.76-3.15],0.2283237705405587
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,20674,262,2.40 [1.64-3.51],6.926851190396945e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",20645,233,2.47 [1.65-3.69],1.0525461480577429e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,21964,293,1.46 [1.01-2.12],0.0461097614549267
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,21955,284,1.48 [1.01-2.16],0.0424097282024948
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22522,553,1.27 [0.96-1.68],0.0890140283071896
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,22061,92,1.06 [0.54-2.11],0.8577799960329702
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,22110,141,1.05 [0.60-1.82],0.8694851097524237
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22321,352,1.34 [0.95-1.89],0.0945054532033147
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,22105,136,1.06 [0.60-1.86],0.8358739521279718
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7346,76,2.51 [1.21-5.22],0.0137595132912241
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20130,1141,1.92 [1.58-2.33],3.5628383321337e-11
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,21578,242,2.48 [1.67-3.67],5.965398044641917e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",21631,295,2.98 [2.11-4.23],7.761051776152526e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",21631,295,2.98 [2.11-4.23],7.761051776152526e-10
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",21558,871,1.43 [1.14-1.78],0.0016630658615741
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,15099,871,1.81 [1.44-2.28],4.0409687217492893e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",14703,871,1.85 [1.47-2.33],1.581987155415123e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15091,863,1.85 [1.47-2.33],1.823914342626069e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22679,123,2.34 [1.36-4.05],0.0022100873460561
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,21602,96,2.69 [1.46-4.95],0.0015151574449817
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",22776,96,2.57 [1.40-4.71],0.0022158522620555
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21595,89,2.73 [1.45-5.14],0.0018223563401602
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,20415,145,2.91 [1.75-4.84],3.917924341922454e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,20562,292,2.50 [1.73-3.61],9.533518226614496e-07
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,21546,131,1.84 [1.07-3.15],0.0274580945643246
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15001,6482,1.82 [1.63-2.04],7.582770495296242e-26
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22800,342,1.21 [0.85-1.72],0.290782819387133
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23251,43,0.76 [0.27-2.11],0.5944635762639789
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,23253,39,0.96 [0.33-2.78],0.9423878960903724
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,22549,91,1.07 [0.54-2.10],0.8516570917782856
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22550,92,1.08 [0.54-2.13],0.8327848323649533
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23247,47,0.60 [0.22-1.61],0.3100805134718424
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22559,101,1.67 [0.89-3.13],0.1073454913360675
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22281,89,1.26 [0.63-2.50],0.5167442878336772
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23141,58,1.20 [0.51-2.82],0.668979407030051
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16415,340,2.23 [1.58-3.15],5.576720978518363e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18642,2567,1.87 [1.63-2.15],4.73378464974665e-19
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,16478,403,2.38 [1.73-3.28],1.057293844048124e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16908,833,1.66 [1.32-2.09],1.850101125297881e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16163,88,1.54 [0.77-3.08],0.2273559053750307
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,16353,278,2.70 [1.85-3.94],2.388455246548966e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,16159,84,2.36 [1.19-4.70],0.0145749771980937
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,16279,204,2.37 [1.52-3.68],0.0001361923885078
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,16217,142,2.13 [1.26-3.62],0.0050276779779344
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23072,96,1.33 [0.70-2.54],0.3808497601830716
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,16220,145,3.27 [1.97-5.43],4.912532048311452e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17066,991,2.32 [1.89-2.85],1.6195936343369733e-15
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,23115,91,1.43 [0.73-2.81],0.30324737053681
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,16560,485,1.53 [1.13-2.08],0.0059840271197866
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16304,229,2.25 [1.47-3.44],0.0001783526056982
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23116,121,1.70 [0.97-2.99],0.0638991050036522
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,23102,78,1.63 [0.79-3.35],0.1868534143775513
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,19591,2078,1.50 [1.29-1.75],9.335153404330672e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,18317,804,1.10 [0.87-1.40],0.4280180084745451
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,17650,137,1.62 [0.95-2.77],0.0788061880436037
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,17623,110,1.47 [0.80-2.70],0.213743578557604
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18636,1123,1.93 [1.59-2.35],3.2757531884667767e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22174,767,1.86 [1.48-2.35],1.4398532551257488e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,17013,2340,1.51 [1.31-1.75],2.37301300435139e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22895,45,3.07 [1.27-7.38],0.0124032252173311
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23187,59,2.93 [1.36-6.33],0.0062699482887369
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,21466,59,3.09 [1.43-6.70],0.0042123092400315
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21452,45,3.20 [1.32-7.72],0.0098546824639164
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23106,143,1.83 [1.08-3.09],0.0246856222895754
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,21550,143,1.91 [1.13-3.24],0.0157649532770057
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21540,133,1.96 [1.14-3.39],0.0157404089805646
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22040,633,1.87 [1.45-2.41],1.401724468959657e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22031,624,1.86 [1.44-2.40],1.97421366996149e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14802,129,1.83 [1.04-3.20],0.0347336454695769
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal stricture,22654,129,1.66 [0.95-2.90],0.0752666607782959
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14756,83,1.53 [0.76-3.07],0.2373422376187347
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15584,911,1.44 [1.15-1.79],0.0013093195957272
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14826,153,1.55 [0.92-2.61],0.1004797592115639
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14992,319,1.85 [1.29-2.65],0.0007692753793477
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,21133,288,1.64 [1.12-2.38],0.0101595358290994
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22754,96,1.37 [0.71-2.63],0.3471285973399634
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14779,106,1.90 [1.04-3.48],0.0358482861119644
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14727,54,2.35 [1.04-5.31],0.0400835794581998
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15652,979,1.38 [1.11-1.71],0.0033875591475587
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,15040,367,1.39 [0.99-1.95],0.057789902730012
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22738,80,1.22 [0.59-2.52],0.5870116611536206
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,22348,127,9.73 [6.16-15.38],1.9827526882416445e-22
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,22294,73,5.73 [2.99-10.97],1.38768736777307e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21740,728,1.98 [1.56-2.51],1.6961174920789534e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,21603,591,1.79 [1.38-2.34],1.552991765623758e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,21133,121,1.92 [1.09-3.40],0.0249116578939193
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21068,56,3.77 [1.76-8.09],0.0006651083644163
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,21087,75,2.66 [1.32-5.36],0.0061353269496144
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23058,75,2.49 [1.24-5.01],0.0106181595860771
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,21735,342,2.50 [1.79-3.48],6.96285996800776e-08
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21467,74,4.10 [2.12-7.93],2.715617864197844e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,21456,63,4.63 [2.32-9.26],1.434021720818624e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",21452,59,2.50 [1.15-5.47],0.021227032734403
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,21607,214,1.87 [1.22-2.88],0.0041701830909895
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,21598,205,1.78 [1.15-2.77],0.0100910874742022
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,19527,1621,1.32 [1.11-1.56],0.0014553457527116
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22715,107,0.80 [0.42-1.52],0.5034070870552119
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22836,442,1.08 [0.79-1.48],0.6343168454907526
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,21151,624,1.31 [1.00-1.70],0.0466998513826963
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22192,392,1.82 [1.33-2.51],0.0002144610365125
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21870,70,1.73 [0.82-3.65],0.1464451027007912
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22081,281,2.15 [1.49-3.11],4.799354639001123e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22938,98,1.28 [0.67-2.45],0.4522243830936706
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22911,71,1.64 [0.78-3.45],0.1879993647715131
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22898,58,1.34 [0.58-3.07],0.4917691483263293
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22815,79,0.92 [0.43-1.95],0.828628435776738
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22813,77,0.96 [0.45-2.05],0.9138426938632144
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22445,51,1.57 [0.65-3.82],0.3172304715761912
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22763,369,0.98 [0.69-1.38],0.891953427605829
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20643,116,0.87 [0.47-1.62],0.660504966048814
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20629,102,1.79 [0.95-3.37],0.0699018019991355
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20597,70,1.56 [0.72-3.37],0.2612642141489517
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20756,229,1.22 [0.79-1.88],0.3788670606461503
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20737,210,1.36 [0.87-2.14],0.1774392226799236
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15167,4440,1.48 [1.32-1.67],1.4871418533809956e-10
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,16779,2766,1.27 [1.11-1.46],0.0006362217065083
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,20612,1298,1.54 [1.28-1.85],3.826131722938893e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14198,185,4.71 [3.08-7.21],7.970832298034089e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14610,597,2.18 [1.68-2.84],5.715128137110844e-09
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22730,179,4.48 [2.95-6.81],2.1827539028984602e-12
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22735,163,4.91 [3.19-7.56],4.915276414369767e-13
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15652,1639,1.15 [0.96-1.37],0.1222952699039215
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",18210,1639,1.09 [0.92-1.30],0.3036134628634011
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14109,96,1.31 [0.67-2.54],0.4307576380842618
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22465,93,1.37 [0.71-2.62],0.3505683522139746
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14311,298,1.39 [0.95-2.03],0.086446156766336
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14132,119,1.29 [0.71-2.36],0.4017000051191729
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14449,436,0.79 [0.56-1.10],0.1552255799064107
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23031,215,0.97 [0.62-1.52],0.8971757531140336
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14740,727,1.20 [0.93-1.55],0.1534238231976375
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14583,570,1.37 [1.03-1.81],0.0277682717156809
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15341,1328,1.12 [0.93-1.36],0.2388864038399253
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14107,94,0.86 [0.43-1.74],0.6834064679193721
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14310,297,1.16 [0.78-1.72],0.4579885400139295
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14089,76,0.88 [0.40-1.92],0.7493567297656198
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14105,92,0.99 [0.49-2.00],0.9691204156084956
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14452,439,0.84 [0.61-1.17],0.3015819845231603
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14409,396,0.76 [0.54-1.08],0.1279680858423113
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17481,274,1.56 [1.05-2.30],0.0271174633191529
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22514,105,4.66 [2.69-8.07],4.2451196609069374e-08
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22482,73,4.48 [2.34-8.58],6.3722159469364015e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19231,78,1.05 [0.50-2.23],0.8896929747610581
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,19527,374,1.43 [1.02-2.00],0.0370704328484996
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,20102,949,1.36 [1.10-1.69],0.0046525651994556
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19396,243,1.59 [1.06-2.41],0.0266569202839572
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19271,118,0.69 [0.37-1.29],0.2452139252370958
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",19851,698,1.30 [1.02-1.68],0.0374459686628337
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19197,44,1.32 [0.50-3.49],0.5792936756741746
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19371,218,0.95 [0.60-1.49],0.8221845494343372
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,19240,87,1.42 [0.71-2.85],0.326481661415535
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19239,86,1.34 [0.67-2.67],0.4118299449963846
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19284,131,1.56 [0.89-2.73],0.1184742327384921
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19214,61,2.42 [1.11-5.28],0.0269962589523351
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19437,284,1.36 [0.93-2.01],0.1149099235321635
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19650,336,1.31 [0.92-1.88],0.1335285015037232
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,19394,80,1.96 [0.98-3.93],0.0577372922472785
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,19434,120,1.94 [1.10-3.44],0.0231790110639586
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,19401,87,0.63 [0.30-1.32],0.2246407848450229
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",19355,41,1.27 [0.46-3.47],0.6465438763922262
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19483,169,2.02 [1.26-3.26],0.0037739866191406
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19472,158,2.03 [1.24-3.32],0.0048491454158368
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19610,296,1.86 [1.29-2.68],0.000804771037963
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19373,59,2.23 [1.01-4.92],0.0476218137586509
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19413,99,1.98 [1.07-3.66],0.0301019525455424
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19452,138,1.88 [1.11-3.19],0.0190997807688947
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19364,50,0.81 [0.31-2.08],0.6541754612670695
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",19767,453,1.50 [1.10-2.03],0.009188638868214
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19499,185,1.66 [1.04-2.65],0.0324945222907519
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19567,253,1.08 [0.72-1.63],0.710803317116095
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,20833,241,1.87 [1.24-2.80],0.0026194505855155
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21028,436,1.74 [1.28-2.36],0.0004333861163175
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20633,41,2.38 [0.91-6.23],0.0776956609124633
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20640,48,0.66 [0.25-1.78],0.4162197812579301
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20680,88,1.40 [0.70-2.81],0.3370936566939728
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16929,4124,1.19 [1.06-1.35],0.003622430597446
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8962,874,0.99 [0.79-1.25],0.935262722542952
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19492,300,1.87 [1.30-2.70],0.0008038612484413
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19276,84,1.43 [0.70-2.91],0.3238618612155058
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19538,65,1.61 [0.74-3.54],0.2328667384297353
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,19562,89,1.91 [0.98-3.71],0.0569849281827619
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19555,82,1.70 [0.85-3.40],0.1362789094781686
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22876,251,1.38 [0.93-2.07],0.1134230373067423
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22639,94,1.55 [0.82-2.96],0.1807960879778695
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22813,188,1.26 [0.79-2.02],0.3302679787847834
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22701,76,1.41 [0.68-2.92],0.3557029983661823
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,20285,1208,1.32 [1.09-1.61],0.0045460230275235
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,19190,113,1.24 [0.67-2.29],0.4914664271376544
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,19174,97,1.72 [0.90-3.28],0.1015713163443846
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19444,367,1.29 [0.92-1.82],0.1450071459862209
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,19219,142,1.46 [0.85-2.50],0.172570704816653
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,19814,737,1.34 [1.05-1.71],0.0188919689853861
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8587,499,1.04 [0.77-1.41],0.7798618931098431
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8159,71,0.44 [0.20-0.98],0.0456008522654164
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,8153,65,1.45 [0.67-3.12],0.3472974917548781
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8160,72,0.84 [0.39-1.80],0.6600714407904065
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8183,95,0.62 [0.32-1.23],0.171288337660925
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8202,114,1.13 [0.62-2.05],0.6943062120270092
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12025,232,1.04 [0.66-1.62],0.8725665720826492
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11870,77,0.90 [0.41-1.97],0.7942158445054062
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,11874,81,1.00 [0.47-2.13],0.9955172934044708
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11852,59,1.63 [0.70-3.80],0.2585567096986876
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12003,166,0.90 [0.53-1.53],0.7029950923621977
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,11888,51,0.70 [0.26-1.86],0.4721686656760389
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11894,57,1.23 [0.51-2.97],0.6404472640876451
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11116,1824,0.98 [0.83-1.17],0.8386921711578728
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Endometriosis,9355,63,2.69 [1.23-5.90],0.013373877542303
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9342,50,2.72 [1.13-6.54],0.025611618079113
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9778,486,1.04 [0.76-1.42],0.8066210481448918
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9396,104,0.89 [0.46-1.72],0.724373273794151
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9779,487,0.72 [0.53-1.00],0.0468665726119747
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9444,152,0.40 [0.23-0.72],0.0019826163419615
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9515,223,1.02 [0.65-1.60],0.9402012479617404
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9309,17,0.69 [0.13-3.76],0.672019690847282
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9340,48,0.68 [0.25-1.84],0.4485391808314234
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",12150,64,0.85 [0.37-1.99],0.71465561562879
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,12152,59,0.94 [0.39-2.26],0.8954876975421266
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,12158,29,1.79 [0.54-5.87],0.3392182263952525
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",12156,33,1.61 [0.52-4.97],0.4072874364549415
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9365,73,2.29 [1.09-4.83],0.0287355864305305
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9347,55,1.31 [0.53-3.23],0.5540722249376191
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9361,69,1.01 [0.45-2.28],0.9723119766077288
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Irregular menses,12157,89,1.78 [0.89-3.57],0.1052316983581691
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9488,196,1.02 [0.62-1.66],0.944467126601934
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9382,90,0.67 [0.33-1.40],0.290776407100269
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",12159,39,1.60 [0.56-4.60],0.3841897229161279
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9403,111,0.70 [0.36-1.36],0.297592089731087
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9341,49,1.22 [0.47-3.18],0.67892680282658
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9932,640,1.10 [0.84-1.44],0.4986381561867723
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22691,86,0.87 [0.43-1.77],0.7033888842612076
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19786,666,1.31 [1.01-1.69],0.0441851893303564
